Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,109 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 35,109 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $2.87 | $17.22 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,863 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 08, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.39 | $20.34 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,857 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 07, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.14 | $18.84 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,851 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 06, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.34 | $20.04 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,845 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 05, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.92 | $23.52 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,839 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 04, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $4.01 | $24.06 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,833 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 01, 2025 Filed Sep 12, 2025 12:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.44 | $20.64 |
DisclosureSEC source: 0001628280-25-041989 · wk-form4_1757680584.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,827 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 31, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.50 | $21.00 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 22 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,821 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 30, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.55 | $21.30 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,815 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 29, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.33 | $19.98 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,809 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 28, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 6 | $3.47 | $20.82 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,803 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 25, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.37 | $26.96 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,797 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 24, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.55 | $28.40 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,789 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 23, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.54 | $28.32 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,781 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 22, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.47 | $27.76 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,773 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 21, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.45 | $27.60 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,765 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 18, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.59 | $28.72 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,757 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 17, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.82 | $30.56 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,749 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 16, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.79 | $30.32 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,741 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 15, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.45 | $27.60 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,733 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 14, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.46 | $27.68 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,725 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 11, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.21 | $25.68 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,717 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 10, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.20 | $25.60 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,709 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 09, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.05 | $24.40 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,701 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 08, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.06 | $24.48 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,693 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 07, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.23 | $25.84 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,685 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 03, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.53 | $28.25 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,677 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 02, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.52 | $28.16 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,669 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 01, 2025 Filed Aug 11, 2025 13:12 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.56 | $28.48 |
DisclosureSEC source: 0001628280-25-039411 · wk-form4_1754917972.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,661 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 30, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $2.74 | $21.92 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 20 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,653 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 27, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $2.60 | $10.40 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 19 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,645 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 26, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $2.71 | $10.84 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 18 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,641 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 25, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $3.27 | $13.08 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 17 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,637 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 24, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $3.91 | $15.64 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 16 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,633 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 23, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $4.61 | $18.44 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 15 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,629 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 20, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.29 | $21.16 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 14 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,625 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 18, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.52 | $22.08 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 13 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,621 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 17, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.61 | $22.44 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 12 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,617 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 16, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.32 | $21.28 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 11 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,613 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 13, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.81 | $23.24 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 10 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,609 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 12, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.67 | $22.68 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 9 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,605 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 11, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.57 | $22.28 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 8 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,601 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 10, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $6.00 | $24.00 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 7 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,597 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 09, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.94 | $23.76 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 6 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,593 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 06, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.57 | $22.28 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 5 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,589 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 05, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.46 | $21.84 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 4 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,585 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 04, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.75 | $23.00 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 3 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,581 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 03, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.61 | $22.44 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 2 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,577 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 02, 2025 Filed Jul 11, 2025 21:50 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $5.20 | $20.80 |
DisclosureSEC source: 0001628280-25-034820 · wk-form4_1752270634.xml · nonDerivative · entry 1 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,573 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 30, 2025 Filed Jun 6, 2025 12:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 4 | $4.93 | $19.72 |
DisclosureSEC source: 0001628280-25-029852 · wk-form4_1749213436.xml · nonDerivative · entry 21 Young Caroline · CIK 0001684087 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,569 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.